# Study of EG-1962 Compared to Standard of Care Oral Nimodipine in Adults With Aneurysmal Subarachnoid Hemorrhage

Study · id `cardio:ct-nct02790632` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02790632](<https://clinicaltrials.gov/study/NCT02790632>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02790632

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It plans to enroll 374 participants.

## Technical summary

Registry record NCT02790632. Randomized; quadruple masking; primary purpose treatment. Start 2016-07 (registry gives no type); primary completion 2018-06 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 374 participants (planned count; ClinicalTrials.gov record NCT02790632, source copy `cardio:ctgov-nct02790632-2018-07-26`, retrieved 2026-10-31)
- Start date: 2016-07 (registry gives no type) (ClinicalTrials.gov record NCT02790632, source copy `cardio:ctgov-nct02790632-2018-07-26`, retrieved 2026-10-31)
- Primary completion: 2018-06 (actual) (ClinicalTrials.gov record NCT02790632, source copy `cardio:ctgov-nct02790632-2018-07-26`, retrieved 2026-10-31)
- Completion: 2018-06 (actual) (ClinicalTrials.gov record NCT02790632, source copy `cardio:ctgov-nct02790632-2018-07-26`, retrieved 2026-10-31)
- Countries: United States; Australia; Austria; Canada; Czechia; Finland; Germany; Hong Kong SAR China; Israel; New Zealand; Singapore (ClinicalTrials.gov record NCT02790632, source copy `cardio:ctgov-nct02790632-2018-07-26`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02790632-2018-07-26`, retrieved 2026-10-31)

## The registry's words

- Brief title: Study of EG-1962 Compared to Standard of Care Oral Nimodipine in Adults With Aneurysmal Subarachnoid Hemorrhage
- Acronym: NEWTON2
- Condition: Subarachnoid Hemorrhage, Aneurysmal
- Intervention (Drug): EG-1962 (nimodipine microparticles)
- Intervention (Drug): Enteral Nimodipine
- Lead sponsor: Edge Therapeutics Inc
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Subarachnoid hemorrhage (`cardio:subarachnoid-hemorrhage`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Single-Dose Intraventricular Nimodipine Microparticles Versus Oral Nimodipine for Aneurysmal Subarachnoid Hemorrhage (`cardio:pubmed-32138631`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 68e318249bfeb89f77e6192a08fa89cb633ef661cb1e7b556479e760270fb271
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
